Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-303-6 | CAS number: 1689576-55-3
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
The potential of two trimellitate esters - tris (2-ethylhexyl) trimellitate (TOTM) containing C8 branched alcohol side chains and 1,2,4-benzenetricarboxylic acid, decyl octyl ester containing linear C8 to C10 alcohol side chains - to induce testicular mal-development(TMD) has been studied in the rat and compared with the positive controls, di- (2-ethylhexyl) phthalate (DEHP) and its active metabolite, mono-(2-ethylhexyl) phthalate (MEHP). The effects of these trimellitates on the expression of genes in pathways involved in steroidogenesis and testes development previously shown to be involved in the induction of TMD by certain phthalate esters were studied using transcriptional profiling techniques on RNA extracted from the testes of rats exposed in utero to either the trimellitate ester or the positive controls.
Additional information
Rats were exposed to two trimellitate esters - either tris (2-ethylhexyl) trimellitate (TOTM) containing C8 branched alcohol side chains or 1,2,4-benzenetricarboxylic acid, decyl octyl ester containing linear C8 to C10 alcohol side chains - in utero by the administration of daily oral gavage doses to pregnant dams between gestational day 12 and 19. The foetal testes were obtained by micro-dissection and prepared to facilitate the isolation of RNA, which was subsequently analysed using whole rat genome microarrays. The study was focussed on assessment of effects in pathways relevant to rat testicular mal-development (TMD). Effects were compared with those of diethylhexyl phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP), an active metabolite of DEHP, both of which were used as a positive controls.
MEHP & DEHP (500 mg/Kg) caused a repression of genes in TMD pathways involved in cholesterol synthesis and transport (HMGCS, HMGCR, STAR, SCARB1, FDFT1, FDPS), Steroidogenesis (Cyp11a, HSD3B1, SC4MOL) and testes development (INSL3, INHA)
The trimellitate esters did not cause significant repression of genes in TMD pathway.
It was concluded that it is highly unlikely that the trimellitate esters will cause testicular mal-development in the rat under these treatment conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
